PeptideDB

Verzistobart

CAS: 2649466-18-0 F: W:

Verzistobart is an IgG1κ antibody targeting the hepatitis A virus cellular receptor HAVCR2.
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity Verzistobart is an IgG1κ antibody targeting the hepatitis A virus cellular receptor HAVCR2.
Target Hepatitis A virus cellular receptor 2, HAVCR2
Name Verzistobart
CAS 2649466-18-0
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.